As methylation levels in the NCAPH2/LMF2 gene promoter region were decreased in the aMCI and AD groups, we could expect that expression of the NCAPH2/LMF2 genes would be elevated but it is unknown whether this was the case because we did not measure mRNA expression. Here, LMF2 is linked to Alzheimer disease.